معرفی
Dr. Max Reijman is an Associate Professor at Erasmus MC, affiliated with the Department of Orthopedics and Sports Medicine within the Faculty of Medicine. His research is centered on clinical orthopedics, with a strong focus on patient-reported outcomes, osteoarthritis, and musculoskeletal injuries including anterior cruciate ligament (ACL) ruptures and total joint arthroplasties.
His research interests span key areas in orthopedic science, including patient-reported outcome measures (PROMs), trauma-related orthopedic conditions, health equity in surgical outcomes, and long-term joint degeneration following injury. He frequently employs randomized controlled trial designs and advanced imaging techniques to evaluate clinical interventions and disease progression.
Dr. Reijman's recent publications demonstrate a consistent focus on improving orthopedic care through evidence-based assessment tools and equitable patient outcomes. His work bridges clinical practice and health services research, particularly in evaluating disparities in hip and knee replacement outcomes and validating health metrics in adolescent populations.
Although no specific scientific awards are listed in the provided text, his extensive publication record in high-impact journals such as Osteoarthritis and Cartilage and Journal of the American College of Cardiology reflects significant scholarly contribution. He has supervised at least 13 junior researchers or students, indicating an active mentoring role.
Dr. Reijman is involved in collaborative research networks, particularly in multi-center clinical studies such as the STARR Study Group, focusing on meniscal injuries and post-traumatic osteoarthritis. His work often involves interdisciplinary teams across Europe and beyond, contributing to both surgical innovation and health policy through outcome analysis.
